Literature DB >> 21765448

Association of the antihypertensive response of iptakalim with KCNJ11 (Kir6.2 gene) polymorphisms in Chinese Han hypertensive patients.

Rui-feng Duan1, Wen-yu Cui, Hai Wang.   

Abstract

AIM: To study the relationship between the antihypertensive response of iptakalim and KCNJ11 polymorphisms in Chinese Han hypertensive patients.
METHODS: One hundred sixty two Chinese Han hypertensive patients were administered iptakalim (5 or 10 mg/d, po) for 8 weeks. Before the treatment and 24 h after completing the treatment blood pressure (BP) was measured. Genotyping was performed using direct sequencing.
RESULTS: Four common A190A, E23K, I337V and 3'UTR +62 G/A polymorphisms were found in KCNJ11. The E23K, I337V and 3'UTR +62 G/A polymorphisms were in complete linkage disequilibrium, and I337V was used as a representative. There were no significant differences in age, body mass index, sex, baseline systolic BP (SBP) and diastolic BP (DBP) among the 3 genotypes for the four polymorphisms. Significant association was found between SBP response and the polymorphisms (adjusted regression coefficient: 3.5 [1.2] mmHg; P=0.003 for the A190A polymorphism; adjusted regression coefficient: 3.1 [1.2] mmHg; P=0.012 for the I337V polymorphism). The patients with TT genotype for A190A polymorphism had higher clinical efficacy than those with CC genotype.
CONCLUSION: The results suggest the KCNJ11 polymorphisms are associated with the SBP-lowering response of short-term iptakalim therapy in Chinese Han hypertensive patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21765448      PMCID: PMC4002535          DOI: 10.1038/aps.2011.85

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  28 in total

1.  Pharmacogenetic effect of the stromelysin (MMP3) polymorphism on stroke risk in relation to antihypertensive treatment: the genetics of hypertension associated treatment study.

Authors:  Richard Sherva; Charles E Ford; John H Eckfeldt; Barry R Davis; Eric Boerwinkle; Donna K Arnett
Journal:  Stroke       Date:  2010-12-23       Impact factor: 7.914

2.  SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci.

Authors:  Yong Yong Shi; Lin He
Journal:  Cell Res       Date:  2005-02       Impact factor: 25.617

3.  Genetic variation in the beta2 subunit of the voltage-gated calcium channel and pharmacogenetic association with adverse cardiovascular outcomes in the INternational VErapamil SR-Trandolapril STudy GENEtic Substudy (INVEST-GENES).

Authors:  Yuxin Niu; Yan Gong; Taimour Y Langaee; Heather M Davis; Hazem Elewa; Amber L Beitelshees; James I Moss; Rhonda M Cooper-Dehoff; Carl J Pepine; Julie A Johnson
Journal:  Circ Cardiovasc Genet       Date:  2010-12

4.  A new ATP-sensitive potassium channel opener reduces blood pressure and reverses cardiovascular remodeling in experimental hypertension.

Authors:  Hai Wang; Chao-Liang Long; Ying-Li Zhang
Journal:  J Pharmacol Exp Ther       Date:  2004-11-03       Impact factor: 4.030

5.  Functional roles of cardiac and vascular ATP-sensitive potassium channels clarified by Kir6.2-knockout mice.

Authors:  M Suzuki; R A Li; T Miki; H Uemura; N Sakamoto; Y Ohmoto-Sekine; M Tamagawa; T Ogura; S Seino; E Marbán; H Nakaya
Journal:  Circ Res       Date:  2001-03-30       Impact factor: 17.367

6.  Kir6.2 polymorphisms sensitize beta-cell ATP-sensitive potassium channels to activation by acyl CoAs: a possible cellular mechanism for increased susceptibility to type 2 diabetes?

Authors:  Michael J Riedel; Parveen Boora; Diana Steckley; Gerda de Vries; Peter E Light
Journal:  Diabetes       Date:  2003-10       Impact factor: 9.461

7.  KCNJ11 Lys23Glu and TCF7L2 rs290487(C/T) polymorphisms affect therapeutic efficacy of repaglinide in Chinese patients with type 2 diabetes.

Authors:  M Yu; X-J Xu; J-Y Yin; J Wu; X Chen; Z-C Gong; H-Y Ren; Q Huang; F-F Sheng; H-H Zhou; Z-Q Liu
Journal:  Clin Pharmacol Ther       Date:  2010-01-06       Impact factor: 6.875

Review 8.  Trends in pharmacogenomics of drugs acting on hypertension.

Authors:  Roberto Trotta; Maria Benedetta Donati; Licia Iacoviello
Journal:  Pharmacol Res       Date:  2004-04       Impact factor: 7.658

9.  KCNJ11 polymorphisms and sudden cardiac death in patients with acute myocardial infarction.

Authors:  A Jeron; C Hengstenberg; S Holmer; B Wollnik; G A J Riegger; H Schunkert; J Erdmann
Journal:  J Mol Cell Cardiol       Date:  2004-02       Impact factor: 5.000

Review 10.  Genetic polymorphisms related to the renin-angiotensin-aldosterone system and response to antihypertensive drugs.

Authors:  Kim Taverne; Mark de Groot; Anthonius de Boer; Olaf Klungel
Journal:  Expert Opin Drug Metab Toxicol       Date:  2010-04       Impact factor: 4.481

View more
  6 in total

1.  A new antihypertensive drug ameliorate insulin resistance.

Authors:  Yan-xia Liu
Journal:  Acta Pharmacol Sin       Date:  2012-04       Impact factor: 6.150

Review 2.  ABCC9/SUR2 in the brain: Implications for hippocampal sclerosis of aging and a potential therapeutic target.

Authors:  Peter T Nelson; Gregory A Jicha; Wang-Xia Wang; Eseosa Ighodaro; Sergey Artiushin; Colin G Nichols; David W Fardo
Journal:  Ageing Res Rev       Date:  2015-07-28       Impact factor: 10.895

3.  The E23K and A190A variations of the KCNJ11 gene are associated with early-onset type 2 diabetes and blood pressure in the Chinese population.

Authors:  Langen Zhuang; Yu Zhao; Weijing Zhao; Ming Li; Ming Yu; Ming Lu; Rong Zhang; Xiaoxu Ge; Taishan Zheng; Can Li; Jun Yin; Jingyuan Yin; Yuqian Bao; Limei Liu; Weiping Jia; Yanjun Liu
Journal:  Mol Cell Biochem       Date:  2015-03-01       Impact factor: 3.396

4.  The novel ATP-sensitive potassium channel opener iptakalim prevents insulin resistance associated with hypertension via restoring endothelial function.

Authors:  Yu Wang; Fu-hu Zeng; Chao-liang Long; Zhi-yuan Pan; Wen-yu Cui; Ru-huan Wang; Guo-shu Liu; Hai Wang
Journal:  Acta Pharmacol Sin       Date:  2011-11-07       Impact factor: 6.150

Review 5.  Genetic Discovery of ATP-Sensitive K+ Channels in Cardiovascular Diseases.

Authors:  Yan Huang; Dan Hu; Congxin Huang; Colin G Nichols
Journal:  Circ Arrhythm Electrophysiol       Date:  2019-05

Review 6.  A Systematically Assembled Signature of Genes to be Deep-Sequenced for Their Associations with the Blood Pressure Response to Exercise.

Authors:  Linda S Pescatello; Paul Parducci; Jill Livingston; Beth A Taylor
Journal:  Genes (Basel)       Date:  2019-04-11       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.